EAM
Erste Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Hold |
260,011
| – | – | 0.02% | 357 |
|
|
2025
Q1 | $3.43M | Buy |
260,011
+86,445
| +50% | +$1.14M | 0.04% | 255 |
|
|
2024
Q4 | $3.26M | Hold |
173,566
| – | – | 0.04% | 278 |
|
|
2024
Q3 | $2.8M | Buy |
173,566
+51,333
| +42% | +$828K | 0.03% | 282 |
|
|
2024
Q2 | $3.31M | Sell |
122,233
-3,089,860
| -96% | -$83.6M | 0.04% | 266 |
|
|
2024
Q1 | $2.09M | Buy |
3,212,093
+85,093
| +3% | +$55.3K | 0.03% | 299 |
|
|
2023
Q4 | $2.16M | Buy |
3,127,000
+600,000
| +24% | +$415K | 0.03% | 289 |
|
|
2023
Q3 | $2.69M | Buy |
2,527,000
+200,000
| +9% | +$213K | 0.05% | 250 |
|
|
2023
Q2 | $2.61M | Buy |
2,327,000
+250,000
| +12% | +$280K | 0.05% | 255 |
|
|
2023
Q1 | $2.88M | Hold |
2,077,000
| – | – | 0.06% | 259 |
|
|
2022
Q4 | $2.35M | Hold |
2,077,000
| – | – | 0.05% | 266 |
|
|
2022
Q3 | $3.4M | Sell |
2,077,000
-500,000
| -19% | -$819K | 0.08% | 238 |
|
|
2022
Q2 | $3.37M | Buy |
2,577,000
+550,000
| +27% | +$719K | 0.07% | 245 |
|
|
2022
Q1 | $2.5M | Buy |
2,027,000
+817,000
| +68% | +$1.01M | 0.05% | 272 |
|
|
2021
Q4 | $4.04M | Buy |
+1,210,000
| New | +$4.04M | 0.07% | 228 |
|